The Bodega Peptide Scam: What Lab Tests Revealed About Those Tiny Vials

On a typical afternoon on Bedford Avenue, the Mr. Green bodega looks just like any other convenience store—candy, rolling papers, a cold soda. Yet tucked behind the candy aisle was a small paper bag containing four unlabeled vials of injectable "peptides". Intrigued, we bought them for $376.20, hoping to see if the hype matched reality.

The four vials, sourced from a vendor called INDR Labs, claimed to be PT‑141 (a libido booster), BPC‑157 (muscle‑repair magic), NAD+ (cellular repair) and retatrutide (weight‑loss). The clerk handed us the bag, shrugged, and sent us on our way. Simple enough, right?

We shipped the vials to Finnrick, an Austin‑based startup that acts as a bridge between curious consumers and independent testing labs. Finnrick doesn’t own a lab; instead, it coordinates analysis for purity, contaminants, and—most importantly—whether the chemistry matches what the label says. A few weeks later, their lab sent back a report that read like a mixed‑bag of relief and alarm.

Good news first: heavy‑metal and endotoxin levels were low, suggesting the liquids weren’t immediately dangerous. Bad news? None of the samples contained the peptides they claimed to hold. The BPC‑157 vial, for instance, was essentially empty of any BPC‑157. The lab could not positively identify any of the listed compounds.

What did the vials actually contain? According to Marco Krause, the CEO of the testing lab, they could only run a “label‑claim analysis.” In plain English, they compare what you say is inside to a known standard. "If it doesn't match, we call it a dud," Krause told us.

This isn’t an isolated incident. Jeff Colhoun, who runs the vendor‑watchdog site Peptide Critic, bought the same INDR Labs products from a nearby smoke shop called Smoker’s World and sent them to a different lab in Texas. That lab also failed to positively identify the substances, hinting at either contamination or severe degradation.

Why might a peptide degrade? Peptides are delicate molecules that need refrigeration and careful handling. A slip in the cold chain, or storage at room temperature for weeks, can break them down into fragments that no longer function—and might not even be detectable.

Beyond storage issues, there’s a broader problem: the market is barely regulated. Many of these compounds sit in a gray zone, marketed as “research‑only” to dodge FDA scrutiny. Public figures—from health‑policy influencers to podcasters—have fanned the flame, making peptides seem like a shortcut to weight loss or injury recovery. Yet, most have never been vetted through the rigorous drug‑approval pipeline, and in many cases they’re illegal to sell for human use.

Finnrick’s CEO Raphaël Mazoyer says the number of “dud” results has risen sharply as more entrepreneurs jump on the peptide bandwagon, often sourcing from the same dubious upstream supplier. He warns that while not every vial is a fraud, the industry’s fragmented nature makes it easy for low‑quality products to proliferate under different brand names.

INDR Labs, the vendor on the label, declined to comment. Shortly after we reached out, their website switched to a login‑only portal, and the certificates of analysis they once posted vanished. An earlier claim that those certificates came from Vanguard Laboratory was flatly denied by Vanguard’s spokesperson, a twist reported earlier by CBS News.

All of this unfolds against a backdrop of a booming peptide economy—Bloomberg estimates the sector could be worth up to $3 billion. The FDA has loosened some rules, and telehealth giants like Hims and Mochi are eyeing peptide sales. Meanwhile, everyday shoppers can still walk into a corner store and walk out with a vial that may be nothing more than saline.

Pharmacist Fred Mills, who works with the nonprofit Americans for Safe and Effective Medicines, says the FDA needs to crack down on these black‑market operations. "If a vial is just water, the worst thing that can happen is you waste money," he notes, "but some mislabeled products have caused real harm, even death." A tragic case earlier this year involved a woman who died after receiving a peptide injection from an unlicensed spa in the Bronx.

Bottom line: buying injectable peptides off the shelf is a gamble. Without transparent testing, you might end up with a pricey placebo—or something dangerous. If you’re tempted to try these substances, the safest move is to consult a qualified medical professional first and steer clear of convenience‑store shelves.